Hyperfine, Inc. (HYPR): Cash & Equivalents
$35.09M
As of 2025-12-31
$43.46M
As of 2026-06-30
-33.2%
3-year compound annual growth
-11.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.09M | -6.8% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $37.65M | -49.9% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $75.18M | -36.0% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $117.47M | -37.7% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $188.50M | +200.7% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $62.68M | n/a | 2022-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $35.09M | -6.8% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $545.8K | +161.1% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $10.41M | +788.4% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.77M | +337.7% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $1.08M | -78.7% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $7.04M | +90.1% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $13.42M | +9.9% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $4.97M | +34.3% |
| Iridex Corp (IRIX) | 2026-01-03 | $6.03M | +152.5% |
Compare HYPR, ESMC, QTI, POCI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗